| 491 |
PITOBRUNIB |
PIRTOBRUTINIB 50 MG |
FILM-COATED TABLETS |
BOTTLE |
TREATMENT OF ADULT PATIENTS WITH RELAPSED OR REFRACTORY MANTLE CELL LYMPHOMA AFTER AT LEAST TWO LINES OF SYSTEMIC THERAPY, INCLUDING A BTK INHIBITOR |
No |
TONGMENG( LAO) PHARMACEUTICAL CO.LTD |
TONGMENG( LAO) PHARMACEUTICAL AND FOOD CO.LTD |
LAO PDR |
CERTIFICATE RELEASED |
11 L 1252/24 |
2024-12-04 |
2029-12-03 |
View |
| 492 |
PITOBRUNIB |
PIRTOBRUTINIB 100 MG |
FILM-COATED TABLETS |
BOTTLE |
TREATMENT OF ADULT PATIENTS WITH RELAPSED OR REFRACTORY MANTLE CELL LYMPHOMA AFTER AT LEAST TWO LINES OF SYSTEMIC THERAPY, INCLUDING A BTK INHIBITOR |
No |
TONGMENG( LAO) PHARMACEUTICAL CO.LTD |
TONGMENG( LAO) PHARMACEUTICAL AND FOOD CO.LTD |
LAO PDR |
CERTIFICATE RELEASED |
11 L 1251/24 |
2024-12-04 |
2029-12-03 |
View |
| 493 |
REMETIRO |
RESMETIROM 100 MG |
FILM-COATED TABLETS |
BOTTLE |
INDICATED IN CONJUNCTION WITH DIET AND EXCERCISE FOR THE TREATMENT OF ADULT WITH NONCIRRHOTIC NONALCOHOLIC STEATOHEPATITIS WITH MODERATE TO ADVANCED LIVER FIBROSIS |
No |
TONGMENG( LAO) PHARMACEUTICAL CO.LTD |
TONGMENG( LAO) PHARMACEUTICAL AND FOOD CO.LTD |
LAO PDR |
CERTIFICATE RELEASED |
11 L 1253/24 |
2024-12-04 |
2029-12-03 |
View |
| 494 |
REMETIRO |
RESMETIROM 80 MG |
FILM-COATED TABLETS |
BOTTLE |
INDICATED IN CONJUNCTION WITH DIET AND EXCERCISE FOR THE TREATMENT OF ADULT WITH NONCIRRHOTIC NONALCOHOLIC STEATOHEPATITIS WITH MODERATE TO ADVANCED LIVER FIBROSIS |
No |
TONGMENG( LAO) PHARMACEUTICAL CO.LTD |
TONGMENG( LAO) PHARMACEUTICAL AND FOOD CO.LTD |
LAO PDR |
CERTIFICATE RELEASED |
11 L 1254/24 |
2024-12-04 |
2029-12-03 |
View |
| 495 |
REMETIRO |
RESMETIROM 60 MG |
FILM-COATED TABLETS |
BOTTLE |
INDICATED IN CONJUNCTION WITH DIET AND EXCERCISE FOR THE TREATMENT OF ADULT WITH NONCIRRHOTIC NONALCOHOLIC STEATOHEPATITIS WITH MODERATE TO ADVANCED LIVER FIBROSIS |
No |
TONGMENG( LAO) PHARMACEUTICAL CO.LTD |
TONGMENG( LAO) PHARMACEUTICAL AND FOOD CO.LTD |
LAO PDR |
CERTIFICATE RELEASED |
11 L 1255/24 |
2024-12-04 |
2029-12-03 |
View |
| 496 |
DYNAPAR QPS |
DICLOFENAC DIETHYLAMINE BP 4.64 %W/V EQ.TO DICLOFENAC SODIUM BP 4 % W/V, ABSOLUTE ALCOHOL BP 10 % V/V |
TOPICAL SOLUTION |
VIAL |
FOR THE SYMPTOMATIC RELIEF OF MILD TO MODERATE PAIN AND INFLAMMATION ASSOCIATION WITH: LOW BACKACHE, SPRAIN AND STRAIN. BLUNT TRAUMA OF THE TENDONS, LIGAMENTS, MUSCLES AND JOINT |
No |
DKSH LAOS COMPANY LIMITED |
TROIKAA PHARMACEUTICALS LIMITED |
INDIA |
CERTIFICATE RELEASED |
05 I 5094/21 |
2024-04-08 |
2027-04-07 |
View |
| 497 |
ELIDEL 10 MG/G CREAM |
PIMECROLIMUS 10 MG/G |
CREAM |
TUBE |
TREATMENT OF PATIENTS AGED 2 YEARS AND OVER WITH MILD OR MODERATE ATOPIC DERMATITIS WHERE TREATMENT WITH TOPICAL CORTICOSTEROID IS EITHER INADVISABLE OR NOT POSSIBLE, THIS MAY INCLUDE: INTOLERANCE TO TOPICAL CORTICOSTEROIDS, LACK OF EFFECT OF TOPICSL CORTICOSTEROID |
No |
DKSH LAOS COMPANY LIMITED |
MEDA MANUFACTURING |
FRANCE |
CERTIFICATE RELEASED |
04 I 5479/23 |
2023-04-25 |
2026-04-24 |
View |
| 498 |
ENO ( ORANGE FLAVOURED |
ANHYDROUS CITRIC ACID 1.85 G, SODIUM BICARBONATE 1.96 G, SODIUM CARBONATE 0.43G |
POWDER |
SACHET |
RELIVES UPSET STOMACH AND THE AFTER EFFECT OF TOO MUCH FOOD |
No |
DKSH LAOS COMPANY LIMITED |
STERLING DRUG (MALAYA) SDN. BHD. |
MALAYSIA |
CERTIFICATE RELEASED |
09 I 4093/15 |
2022-08-23 |
2025-08-22 |
View |
| 499 |
ESOWAN 40 |
ESOMEPRAZOLE TRIHYDRATE USP EQ.TO ESOMEPRAZOLE 40 MG |
TABLET |
ALU-ALU BLISTER |
TREATMENT OF EROSIVE REFLUX ESOPHAGITIS, LONG TERM MANAGEMENT OF PATIENTS WITH HEALED ESOPHAGITIS TO PREVENT RELAPSE, SYMPTOMATIC TREATMENT OF GASTROESOPHAGEAL REFLUX DISEASE |
Yes |
DKSH LAOS COMPANY LIMITED |
ARGON REMEDIES PVT LTD |
INDIA |
CERTIFICATE RELEASED |
02 I 5692/24 |
2024-02-26 |
2027-02-25 |
View |
| 500 |
FAMY-DEPO |
MEDROXYPROGESTERONE ACETATE 150 MG/ML |
SUSPENSION FOR INJECTION |
VIAL |
FOR CONTRACEPTION |
Yes |
DKSH LAOS COMPANY LIMITED |
MYLAN LABORATORIES LTD |
INDIA |
CERTIFICATE RELEASED |
03 I 4029/15 |
2022-09-14 |
2025-09-13 |
View |
